Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.
Saved in:
| Title: | Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma. |
|---|---|
| Authors: | Luwor R; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia., Morokoff AP; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.; b Department of Neurosurgery , The Royal Melbourne Hospital , Parkville , Australia., Amiridis S; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.; c Department of Medicine , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia., D'Abaco G; d Melbourne School of Engineering, School of Chemical and Biomedical Engineering , The University of Melbourne , Parkville , Australia., Paradiso L; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia., Stylli SS; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.; b Department of Neurosurgery , The Royal Melbourne Hospital , Parkville , Australia., Nguyen HPT; a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia., Tarleton M; e Department of Chemistry, School of Environmental and Life Sciences , The University of Newcastle , Callaghan , Australia., Young KA; e Department of Chemistry, School of Environmental and Life Sciences , The University of Newcastle , Callaghan , Australia., O'Brien TJ; c Department of Medicine , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.; f Department of Neuroscience , Central Clinical School, Monash University , Melbourne , Australia.; g Department of Neurology , The Alfred Hospital , Melbourne , Australia., Robinson PJ; e Department of Chemistry, School of Environmental and Life Sciences , The University of Newcastle , Callaghan , Australia.; h Children's Medical Research Institute, The University of Sydney , Westmead , Australia., Chircop M; e Department of Chemistry, School of Environmental and Life Sciences , The University of Newcastle , Callaghan , Australia.; h Children's Medical Research Institute, The University of Sydney , Westmead , Australia., McCluskey A; e Department of Chemistry, School of Environmental and Life Sciences , The University of Newcastle , Callaghan , Australia., Jones NC; c Department of Medicine , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.; f Department of Neuroscience , Central Clinical School, Monash University , Melbourne , Australia.; g Department of Neurology , The Alfred Hospital , Melbourne , Australia. |
| Source: | Cancer investigation [Cancer Invest] 2019; Vol. 37 (3), pp. 144-155. Date of Electronic Publication: 2019 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
